MX2017013285A - Ratones con genes insertados de sirpa-il15 humanizadas y métodos para usarlos. - Google Patents

Ratones con genes insertados de sirpa-il15 humanizadas y métodos para usarlos.

Info

Publication number
MX2017013285A
MX2017013285A MX2017013285A MX2017013285A MX2017013285A MX 2017013285 A MX2017013285 A MX 2017013285A MX 2017013285 A MX2017013285 A MX 2017013285A MX 2017013285 A MX2017013285 A MX 2017013285A MX 2017013285 A MX2017013285 A MX 2017013285A
Authority
MX
Mexico
Prior art keywords
human
methods
sirpa
animal genome
animals expressing
Prior art date
Application number
MX2017013285A
Other languages
English (en)
Inventor
J Murphy Andrew
Gurer Cagan
Stevens Sean
A Flavell Richard
D Yancopoulos George
Shan Liang
Herndler-Brandstetter Dietmar
FRLETA Davor
Gabriel MANZ Markus
W Palm Noah
Strowig Till
DE ZOETE Marcel
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of MX2017013285A publication Critical patent/MX2017013285A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5443—IL-15
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/12—Animals modified by administration of exogenous cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0331—Animal model for proliferative diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0337—Animal models for infectious diseases

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Se proporcionan animales no humanos modificados genéticamente que expresan SIRPa e lL-15 humana a partir del genoma de animales no humanos. También se proporcionan métodos para llevar a cabo animales no humanos que expresan SIRPa e IL-15 humanas a partir del genoma de animales no humanos, y métodos para utilizar los animales no humanos que expresan SIRPa humana e IL - 15 a partir del genoma animal no humano. Estos animales y métodos tienen varios usos en la técnica que incluyen, por ejemplo, modelar el desarrollo y función de los linfocitos citolíticos T y/o linfocitos citoliticos naturales (NK), en el modelado de la infección con el patógeno humano de linfocitos T y/o linfocvitos NK humanos y en varios análisis in vivo.
MX2017013285A 2015-04-13 2016-04-12 Ratones con genes insertados de sirpa-il15 humanizadas y métodos para usarlos. MX2017013285A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562146938P 2015-04-13 2015-04-13
US201562148667P 2015-04-16 2015-04-16
US201662287842P 2016-01-27 2016-01-27
PCT/US2016/027164 WO2016168212A1 (en) 2015-04-13 2016-04-12 Humanized sirpa-il15 knockin mice and methods of use thereof

Publications (1)

Publication Number Publication Date
MX2017013285A true MX2017013285A (es) 2018-08-01

Family

ID=55910354

Family Applications (3)

Application Number Title Priority Date Filing Date
MX2017013285A MX2017013285A (es) 2015-04-13 2016-04-12 Ratones con genes insertados de sirpa-il15 humanizadas y métodos para usarlos.
MX2022001201A MX2022001201A (es) 2015-04-13 2017-10-13 Ratones con genes insertados de sirp¿-il15 humanizadas y métodos para usarlos.
MX2022001202A MX2022001202A (es) 2015-04-13 2017-10-13 Ratones con genes insertados de sirp¿-il15 humanizadas y métodos para usarlos.

Family Applications After (2)

Application Number Title Priority Date Filing Date
MX2022001201A MX2022001201A (es) 2015-04-13 2017-10-13 Ratones con genes insertados de sirp¿-il15 humanizadas y métodos para usarlos.
MX2022001202A MX2022001202A (es) 2015-04-13 2017-10-13 Ratones con genes insertados de sirp¿-il15 humanizadas y métodos para usarlos.

Country Status (16)

Country Link
US (4) US10123518B2 (es)
EP (2) EP3282835B1 (es)
JP (2) JP6752221B2 (es)
KR (2) KR20240060648A (es)
CN (3) CN115943929A (es)
AU (2) AU2016247892B2 (es)
CA (1) CA2981186A1 (es)
DK (1) DK3282835T3 (es)
ES (1) ES2950399T3 (es)
FI (1) FI3282835T3 (es)
IL (2) IL254727B2 (es)
MX (3) MX2017013285A (es)
PT (1) PT3282835T (es)
RU (1) RU2730599C2 (es)
SG (2) SG10202103445QA (es)
WO (1) WO2016168212A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2485583B1 (en) 2009-10-06 2016-07-06 Regeneron Pharmaceuticals, Inc. Genetically modified mice and engraftment
SG10202008003VA (en) 2011-02-15 2020-10-29 Regeneron Pharma Humanized m-csf mice
KR101823513B1 (ko) * 2011-09-21 2018-01-30 엘지전자 주식회사 히트 펌프, 이를 구비한 공기 조화기, 및 온수 순환 시스템
CN108782459B (zh) 2012-09-07 2021-11-05 再生元制药公司 经遗传修饰的非人动物及其使用方法
JP6422441B2 (ja) 2012-11-05 2018-11-14 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 遺伝学的に修飾された非ヒト動物およびその使用法
WO2015179317A2 (en) 2014-05-19 2015-11-26 Regeneron Pharmaceuticals, Inc. Genetically modified non-human animals expressing human epo
MX2017013285A (es) 2015-04-13 2018-08-01 Regeneron Pharma Ratones con genes insertados de sirpa-il15 humanizadas y métodos para usarlos.
CN108467873B (zh) 2017-03-17 2020-03-13 百奥赛图江苏基因生物技术有限公司 一种cd132基因缺失的免疫缺陷动物模型的制备方法及应用
CN108588126B (zh) 2017-03-31 2020-04-10 北京百奥赛图基因生物技术有限公司 Cd47基因人源化改造动物模型的制备方法及应用
CN116998459A (zh) * 2017-08-09 2023-11-07 杰克逊实验室 表达人白介素15的免疫缺陷小鼠
EP3823443B1 (en) 2018-07-16 2024-05-22 Regeneron Pharmaceuticals, Inc. Rodent models of ditra disease and uses thereof
CN111837036B (zh) * 2018-12-17 2024-06-18 百奥赛图江苏基因生物技术有限公司 具有人或嵌合基因的基因修饰的非人动物
WO2020135518A1 (en) * 2018-12-25 2020-07-02 Biocytogen Jiangsu Co., Ltd. Genetically modified non-human animal with human or chimeric il15
CN114786479B (zh) * 2019-12-25 2023-12-15 江苏集萃药康生物科技股份有限公司 一种il-15人源化小鼠模型及其用途
WO2021136537A1 (en) * 2019-12-31 2021-07-08 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. GENETICALLY MODIFIED IMMUNODEFICIENT NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC SIRPα/CD47
CN111485001A (zh) * 2020-04-14 2020-08-04 澎立生物医药技术（上海）有限公司 具有nk细胞及adcc能力的人源化免疫***小鼠的构建方法
EP4138550A1 (en) * 2020-04-21 2023-03-01 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized cxcl13 gene
CN111926039B (zh) * 2020-09-23 2021-03-16 百奥赛图(北京)医药科技股份有限公司 Il-13基因人源化的非人动物的构建方法和应用
US20240102045A1 (en) 2022-07-19 2024-03-28 Regeneron Pharmaceuticals, Inc. Vectors, genetically modified cells, and genetically modified non-human animals comprising the same
WO2024039744A1 (en) * 2022-08-16 2024-02-22 Ourotech, Inc. Methods of forming patient-derived 3d cell cultures for tracking live immune-tumor interactions
WO2024123682A1 (en) * 2022-12-05 2024-06-13 Shoreline Biosciences, Inc. Methods and compositions for generating modified pluripotent cells and derivates thereof
CN117625480B (zh) * 2023-11-30 2024-05-31 吉林农业大学 一株粪肠球菌及其在抗猪轮状病方面的应用

Family Cites Families (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870009A (en) 1982-11-22 1989-09-26 The Salk Institute For Biological Studies Method of obtaining gene product through the generation of transgenic animals
US4736866B1 (en) 1984-06-22 1988-04-12 Transgenic non-human mammals
US5573930A (en) 1985-02-05 1996-11-12 Cetus Oncology Corporation DNA encoding various forms of colony stimulating factor-1
JP2644794B2 (ja) 1986-10-24 1997-08-25 カイロン コーポレイション 新規な型のコロニー刺激因子―１
ATE119197T1 (de) 1987-12-23 1995-03-15 Univ Leland Stanford Junior Schimäre immunkompromittierende säugetiere und ihre verwendung.
JP2981486B2 (ja) 1988-06-14 1999-11-22 メディカル・バイオロジー・インスティチュート 哺乳動物の免疫系研究方法
US5652373A (en) 1990-01-15 1997-07-29 Yeda Research And Development Co. Ltd. Engraftment and development of xenogeneic cells in normal mammals having reconstituted hematopoetic deficient immune systems
US5849288A (en) 1990-01-15 1998-12-15 Yeda Research And Development Co. Ltd. Method for production of monoclonal antibodies in chimeric mice or rats having xenogeneic antibody-producing cells
DK0438053T3 (da) 1990-01-15 1999-11-22 Yeda Res & Dev Varig transplantation og udvikling af humane hæmopoietiske cellelinjer i normale pattedyr
AU637914B2 (en) 1990-05-03 1993-06-10 Systemix, Inc. Human lymphoid tissue in an immunocompromised host
WO1991018615A1 (en) 1990-05-25 1991-12-12 Systemix, Inc. Human peripheral blood cells in an immunocompromised host
US5633426A (en) 1990-05-25 1997-05-27 Systemix, Inc. In vivo use of human bone marrow for investigation and production
US5770429A (en) * 1990-08-29 1998-06-23 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5222982A (en) 1991-02-11 1993-06-29 Ommaya Ayub K Spinal fluid driven artificial organ
JPH06505186A (ja) 1991-02-11 1994-06-16 オマーヤ，アユブ　ケー． 脊髄液駆動式人工器官
EP0517199A1 (en) 1991-06-04 1992-12-09 Yeda Research And Development Company, Ltd. Durable engraftment of human tissue and cells in normal mammals
WO1993005796A1 (en) 1991-09-19 1993-04-01 The Scripps Research Institute Method for producing human antibodies in a non-human animal, and animals therefor
DE69229254T2 (de) 1991-10-30 1999-09-23 Idemitsu Kosan Co. Ltd., Tokio/Tokyo Verfahren zur Herstellung von menschlichen Lymphozyten und menschlichen Antikörpern; und so hergestellte Antikörper
US6353150B1 (en) 1991-11-22 2002-03-05 Hsc Research And Development Limited Partnership Chimeric mammals with human hematopoietic cells
WO1993018144A1 (en) 1992-03-05 1993-09-16 The Trustees Of Columbia University Of The City Of New York Recombination activating gene deficient animal
US5866757A (en) 1992-06-02 1999-02-02 Yeda Research And Development Co. Ltd. Engraftment and development of xenogeneic cells in normal mammals having reconstituted hematopoetic deficient immune systems
US6018096A (en) 1993-05-03 2000-01-25 Surrogen, Inc. Animal model for engraftment, proliferation and differentiation of human hematopoietic stem cells
CA2103693A1 (en) 1993-08-06 1995-02-07 Steven Gallinger Animal model of the human immune system
WO1996003495A1 (en) 1994-07-27 1996-02-08 Merck & Co., Inc. Bradykinin b2 receptor modified transgenic non-human animals
US6455756B1 (en) 1994-08-12 2002-09-24 Novartis Ag Long term xenogeneic myeloid and lymphoid cell production in chimeric immunocompromised mice
US7273753B2 (en) 1996-08-02 2007-09-25 Center Of Blood Research Purification and uses of dendritic cells and monocytes
US6248721B1 (en) 1997-04-09 2001-06-19 Lung-Ji Chang Method of using mouse model for evaluation of HIV vaccines
CA2284689C (en) 1997-04-09 2009-10-06 Lung-Ji Chang Animal model for evaluation of vaccines
US20030028911A1 (en) 1999-08-31 2003-02-06 Manley Huang Transgenic mammal capable of facilitating production of donor-specific functional immunity
WO2001015521A1 (en) 1999-08-31 2001-03-08 Genencor International, Inc. Transgenic mammal capable of facilitating production of donor-specific functional immunity
EP1244807A1 (en) 1999-12-09 2002-10-02 Human Genome Sciences, Inc. Il-6 like polynucleotide
AU2001290855A1 (en) 2000-09-14 2002-03-26 Genetrol Biotherapeutics, Inc. Method and cell composition for screening compounds for anti-inflammatory activity
US6596541B2 (en) 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
WO2003039232A2 (en) 2001-10-26 2003-05-15 Large Scale Biology Corporation Endothelial cell derived hemotopoietic growth factor
US20050177884A1 (en) 2001-11-15 2005-08-11 Kirin Beer Kabushiki Kaisha Chimeric nonhuman animal
WO2004005496A1 (ja) 2002-07-05 2004-01-15 Kirin Beer Kabushiki Kaisha 臍帯血、骨髄、末梢血等に含まれる新規な未分化幹細胞集団
CN101250553A (zh) 2002-07-13 2008-08-27 上海医学遗传研究所 一种促人血小板生成素表达载体及其构建方法
EP1539946A4 (en) 2002-09-09 2006-03-15 California Inst Of Techn METHOD AND COMPOSITIONS FOR PRODUCING HUMANIZED MICE
IL152232A0 (en) * 2002-10-10 2003-05-29 Yeda Res & Dev Promoter to il-18bp, its preparation and use
EP1418185A1 (en) 2002-11-11 2004-05-12 Aventis Pharma Deutschland GmbH Use of EDG2 receptor in an animal model of heart failure
KR20050084318A (ko) 2002-12-16 2005-08-26 제넨테크, 인크. 인간 ｃｄ２０을 발현하는 트랜스제닉 마우스
CN1748143A (zh) 2002-12-16 2006-03-15 健泰科生物技术公司 表达人cd20和/或cd16的转基因小鼠
CU23472A1 (es) * 2004-09-17 2009-12-17 Ct Ingenieria Genetica Biotech Péptido antagonista de la interleucina-15
DK2767161T3 (en) 2004-10-19 2018-05-07 Regeneron Pharma Method of generating an animal homozygous for genetic modification
US7759541B2 (en) 2004-12-13 2010-07-20 Iti Life Sciences Transgenic animals for assessing drug metabolism and toxicity
GB2434578A (en) 2006-01-26 2007-08-01 Univ Basel Transgenic animals
BRPI0710800A2 (pt) 2006-04-25 2012-01-17 Univ California administração de fatores de crescimento para o tratamento de distúrbios de snc
EP1878342A1 (en) 2006-07-13 2008-01-16 Institut Pasteur Immunodeficient mice transgenic for HLA class I and HLA class II molecules and their uses
US20080081064A1 (en) 2006-09-28 2008-04-03 Surmodics, Inc. Implantable Medical Device with Apertures for Delivery of Bioactive Agents
EP2088854A1 (en) 2006-12-05 2009-08-19 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Improved xenogenic immune system in a non-human mammal
AU2008262487B2 (en) 2007-05-23 2013-10-31 Sangamo Therapeutics, Inc. Methods and compositions for increased transgene expression
TW200848431A (en) * 2007-06-12 2008-12-16 Trubion Pharmaceuticals Inc Single-chain multivalent binding proteins with effector function
WO2009013319A1 (en) * 2007-07-23 2009-01-29 Bioxell Spa Screening, therapy and diagnosis
GB0718029D0 (en) 2007-09-14 2007-10-24 Iti Scotland Ltd Two step cluster deletion and humanisation
WO2009042917A1 (en) 2007-09-28 2009-04-02 The General Hospital Corporation Methods and compositions for antibody production
WO2009097468A2 (en) 2008-01-29 2009-08-06 Kliman Gilbert H Drug delivery devices, kits and methods therefor
ES2665068T3 (es) 2008-03-07 2018-04-24 Regeneron Pharmaceuticals, Inc. Ratones derivados de células ES a partir de inyección de un embrión hospedador diploide
AU2013204613A1 (en) * 2008-12-24 2013-05-16 The Kingdom of The Netherlands, Represented by The Minister of Health, Welfare and Sport Modified Streptococcus pneumonia pneumolysin (PLY) polypeptides
EP2414523B1 (en) * 2009-04-03 2020-07-22 INSERM (Institut National de la Santé et de la Recherche Médicale) Dendritic cell-boosted humanized immune system mice
JP2012531894A (ja) 2009-06-29 2012-12-13 レスコフ，イリヤ，ビー． ヒト血液癌の非ヒト哺乳動物モデル
CN102725400A (zh) * 2009-06-29 2012-10-10 麻省理工学院 制造人源化的非人类哺乳动物的方法
RU2425880C2 (ru) * 2009-07-30 2011-08-10 Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН Способ получения трансгенных мышей
JP2013501528A (ja) * 2009-08-14 2013-01-17 レビビコア， インコーポレイテッド 糖尿病の処置のためのマルチ・トランスジェニック・ブタ
EP2485583B1 (en) 2009-10-06 2016-07-06 Regeneron Pharmaceuticals, Inc. Genetically modified mice and engraftment
RU2549695C2 (ru) * 2009-12-21 2015-04-27 Ридженерон Фармасьютикалз, Инк. ГУМАНИЗИРОВАННЫЕ FCγR МЫШИ
WO2012040207A2 (en) * 2010-09-20 2012-03-29 Yale University HUMAM SIRPAα TRANSGENIC ANIMALS AND THEIR METHODS OF USE
WO2012051572A1 (en) 2010-10-15 2012-04-19 Massachusetts Institute Of Technology A humanized non-human mammal model of malaria and uses thereof
SG10202008003VA (en) 2011-02-15 2020-10-29 Regeneron Pharma Humanized m-csf mice
DK2747551T3 (da) * 2011-08-26 2020-05-18 Yecuris Corp Fumarylacetoacetate-hydrolase (FAH)-deficiente og immundeficiente rotter og anvendelser deraf
EP2663575B1 (en) 2011-10-28 2014-10-01 Regeneron Pharmaceuticals, Inc. Humanized il-6 and il-6 receptor
HUE045879T2 (hu) * 2011-10-28 2020-01-28 Regeneron Pharma Genetikailag módosított fõ hisztokompatibilitási komplexes egerek
EP2644027A1 (en) * 2012-03-26 2013-10-02 Institut Pasteur Transgenic immunodefficient mouse expressing human SIRPalpha.
US8962913B2 (en) * 2012-06-18 2015-02-24 Regeneron Pharmaceuticals, Inc. Humanized IL-7 rodents
CN108782459B (zh) 2012-09-07 2021-11-05 再生元制药公司 经遗传修饰的非人动物及其使用方法
JP6422441B2 (ja) 2012-11-05 2018-11-14 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 遺伝学的に修飾された非ヒト動物およびその使用法
PT2922394T (pt) 2013-09-23 2017-05-22 Regeneron Pharma Animais não-humanos tendo um gene humanizado da proteína reguladora de sinal
SI2908626T1 (sl) * 2013-10-15 2017-02-28 Regeneron Pharmaceuticals, Inc. Humanizirane živali IL-15
WO2015179317A2 (en) 2014-05-19 2015-11-26 Regeneron Pharmaceuticals, Inc. Genetically modified non-human animals expressing human epo
MX2017013285A (es) * 2015-04-13 2018-08-01 Regeneron Pharma Ratones con genes insertados de sirpa-il15 humanizadas y métodos para usarlos.
RU2019100328A (ru) * 2016-06-29 2020-07-29 Менло Терапеутикс Инк. Применение антагонистов нейрокинина-1 для терапии различных симптомов зуда

Also Published As

Publication number Publication date
CN107896479A (zh) 2018-04-10
PT3282835T (pt) 2023-07-25
KR20240060648A (ko) 2024-05-08
SG11201708380WA (en) 2017-11-29
EP3282835A1 (en) 2018-02-21
CN113424798B (zh) 2023-01-13
JP7088992B2 (ja) 2022-06-21
US10561126B2 (en) 2020-02-18
IL254727A0 (en) 2017-11-30
JP6752221B2 (ja) 2020-09-09
CN115943929A (zh) 2023-04-11
ES2950399T3 (es) 2023-10-09
WO2016168212A1 (en) 2016-10-20
AU2016247892A1 (en) 2017-10-19
US20230292721A1 (en) 2023-09-21
FI3282835T3 (fi) 2023-07-20
JP2018512156A (ja) 2018-05-17
JP2020202853A (ja) 2020-12-24
KR20180019521A (ko) 2018-02-26
US10123518B2 (en) 2018-11-13
US20160295844A1 (en) 2016-10-13
RU2730599C2 (ru) 2020-08-24
IL302370A (en) 2023-06-01
US20200229410A1 (en) 2020-07-23
MX2022001201A (es) 2022-02-22
AU2022221378A1 (en) 2022-09-15
US20180295820A1 (en) 2018-10-18
EP3282835B1 (en) 2023-05-31
JP2022111334A (ja) 2022-07-29
RU2020124128A (ru) 2020-09-22
IL254727B2 (en) 2023-10-01
IL254727B1 (en) 2023-06-01
CN107896479B (zh) 2021-07-13
US11576356B2 (en) 2023-02-14
DK3282835T3 (da) 2023-06-26
CN113424798A (zh) 2021-09-24
EP4248740A3 (en) 2023-12-27
KR102658190B1 (ko) 2024-04-17
SG10202103445QA (en) 2021-05-28
CA2981186A1 (en) 2016-10-20
AU2016247892B2 (en) 2022-05-26
EP4248740A2 (en) 2023-09-27
MX2022001202A (es) 2022-02-22
RU2017139008A3 (es) 2019-07-17
RU2017139008A (ru) 2019-05-13

Similar Documents

Publication Publication Date Title
MX2022001201A (es) Ratones con genes insertados de sirp¿-il15 humanizadas y métodos para usarlos.
CY1121405T1 (el) Εξανθρωποποιημενα il-15 ζωα
CY1121223T1 (el) Ποντικοι οι οποιοι εκφραζουν ανθρωποποιημενο μειζον συμπλεγμα ιστοσυμβατοτητας
CY1121410T1 (el) Μη-ανθρωπινα ζωα που εχουν ενα εξανθρωποποιημενο γονιδιο ρυθμιστικης πρωτεϊνης σηματος
CY1123714T1 (el) Μη-ανθρωπινα ζωα που εκφραζουν ανθρωποποιημενο cd3 συμπλοκο
CY1122940T1 (el) Μη ανθρωπινα ζωα που εχουν ενα εξανθρωπισμενο γονιδιο προγραμματισμενου κυτταρικου θανατου 1
CY1119071T1 (el) Εξανθρωποποιημενα il-7 τρωκτικα
EP4306648A3 (en) Genetically modified mice expressing human epo
MX2017004980A (es) Genomas humanos ancestrales.
WO2014130671A8 (en) Mice expressing humanized t-cell co-receptors
EA202090931A2 (ru) Композиции и способы перепрограммирования tcr с помощью гибридных белков
MY175954A (en) Light-sensitive ion-passing molecules
MX355726B (es) Ratones transgenicos que expresan moleculas quimericas del complejo mayor de histocompatibilidad (cmh) clase ii.
MX361533B (es) Anticuerpos anti-cd22.
MY164836A (en) Genetically modified major histocompatibility complex mice
MX2016006511A (es) Animales no humanos que tienen un gen del factor activador de celulas b.
MX358206B (es) Animales no humanos que tienen un gen humanizado de un ligando inductor de la proliferacion.
PH12016502170A1 (en) Humanized dipeptidyl peptidase iv (dpp4) animals
EP4249507A3 (en) Transgenic mice expressing chimeric major histocompatibility complex (mhc) class ii molecules
NZ720244A (en) Methods of feeding fish fermentation cell mass
GB201805033D0 (en) Genetically-modified human natural killer (nk) cell
GB201805031D0 (en) Genetically-modified human natural killer (nk) cell
GB201705338D0 (en) Genetically-modified human natural killer (NK) cell
NZ716947A (en) An aquatic life husbandry system
GB201509735D0 (en) Helly's whales. (First of the collection Helly's Animals)